{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:54:24Z","timestamp":1793818464107,"version":"4.6.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and objectives:<\/jats:title>\n            <jats:p>Chemotherapy does not only affect cancer cells; it also affects, to a greater or lesser degree, all other cells in the body. This toxicity should be assessed according to its severity, frequency, and duration, taking into account objective and subjective dimensions in its assessment. This assessment is a highly relevant aspect when providing care to chemotherapy patients, mainly due to the impact of the treatment on the patient's quality of life, as well as the vital risk it may imply under certain circumstances. For all this, the objective of this study was to assess the relationship between chemotherapy-associated adverse reactions and health-related quality of life in breast cancer patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods:<\/jats:title>\n            <jats:p>With this purpose, a descriptive cross-sectional study was developed on 110 breast cancer patients who were treated with docetaxel, epirubicin, and cyclophosphamide.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>It is worth highlighting the negative effect of nausea, dysgeusia, peripheral neuropathy, loss of appetite, myalgia, and peripheral edema on the quality of life. Likewise, it is worth mentioning peripheral neuropathy as the toxicity that affects a greater number of quality-of-life indicators.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>To sum up, it would be necessary to make health professionals aware of the importance of chemotherapy-associated adverse reactions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021695","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T06:14:54Z","timestamp":1597299294000},"page":"e21695","source":"Crossref","is-referenced-by-count":91,"title":["Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer"],"prefix":"10.1097","volume":"99","author":[{"given":"Blanca","family":"Prieto-Callejero","sequence":"first","affiliation":[{"name":"Hospital Virgen de la Bella, Lepe, Huelva"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Rivera","sequence":"additional","affiliation":[{"name":"Department of Experimental Psychology, Faculty of Psychology, University of Seville, Seville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Fagundo-Rivera","sequence":"additional","affiliation":[{"name":"Department of Health and Emergencies, Spanish Red Cross, Local Committee of Seville, Doctoral Programme, University of Huelva, Huelva"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Romero","sequence":"additional","affiliation":[{"name":"University Hospital Virgen de la Victoria, Nursing and Podiatry Department, Health Sciences School, University of M\u00e1laga, M\u00e1laga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Romero-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Nursing Department, Faculty of Nursing, University of Huelva"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"G\u00f3mez-Salgado","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Public Health Unit, Sociology, Social Work and Public Health Department, Labour Sciences Faculty, University of Huelva, Huelva, Spain"},{"name":"Safety and Health Postgraduate Programme, Universidad Esp\u00edritu Santo, Guayaquil, Ecuador."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ruiz-Frutos","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Public Health Unit, Sociology, Social Work and Public Health Department, Labour Sciences Faculty, University of Huelva, Huelva, Spain"},{"name":"Safety and Health Postgraduate Programme, Universidad Esp\u00edritu Santo, Guayaquil, Ecuador."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-4858(03)74432-1","article-title":"Quimioterapia: efectos secundarios","volume":"100","author":"Ferreiro","year":"2003","journal-title":"Gac Med Bilbao"},{"key":"R2-20230915","first-page":"1","article-title":"Toxicidad hematol\u00f3gica de la quimioterapia","volume":"33","author":"Ram\u00edrez-Ruda","year":"2019","journal-title":"Revisiones c\u00e1ncer"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jgo.2018.08.010","article-title":"Predicting chemotherapy toxicity in older adults: comparing the predictive value of the CARG Toxicity Score with oncologists\u2019 estimates of toxicity based on clinical judgement","volume":"10","author":"Moth","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"2","DOI":"10.22141\/oncology.2.1.2019.165445","article-title":"Delays in cycles and reduction of chemotherapy dose reduce the effectiveness of treatment in patients with ovarian cancer","volume":"2","author":"Kolesnik","year":"2019","journal-title":"Pract Oncol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"191","DOI":"10.12998\/wjcc.v7.i2.191","article-title":"Cardiac involvement in disseminated diffuse large B-cell lymphoma, successful management with chemotherapy dose reduction guided by cardiac imaging: a case report and review of literature","volume":"7","author":"Al-Mehisen","year":"2019","journal-title":"World J Clin Cases"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1111\/jns.12337","article-title":"Chemotherapy-induced peripheral neurotoxicity: a multifaceted, still unsolved issue","volume":"24","author":"Cavaletti","year":"2019","journal-title":"J Peripher Nerv Syst"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1130-6343(07)75390-4","article-title":"Intensidad de dosis recibida en el tratamiento quimioter\u00e1pico del c\u00e1ncer de mama","volume":"31","author":"Qui\u00f1ones-Ribas","year":"2007","journal-title":"Farm Hosp"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jhqr.2019.04.002","article-title":"Quimioterapia al final de la vida: \u00bfpr\u00e1ctica cl\u00ednica poco frecuente?","volume":"34","author":"Santos-P\u00e9rez","year":"2019","journal-title":"J Healthcare Quality Res"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"149","DOI":"10.6004\/jnccn.2012.0018","article-title":"Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives","volume":"10","author":"Salsman","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5209\/rev_PSIC.2014.v11.n2-3.47391","article-title":"Calidad de vida en c\u00e1ncer de mama metast\u00e1sico de larga evoluci\u00f3n: La opini\u00f3n de las pacientes","volume":"11","author":"Falo Zamora","year":"2014","journal-title":"Psicooncolog\u00eda"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"v844","DOI":"10.1093\/annonc\/mdz276.031","article-title":"Nursing management of fatigue in cancer patients: mixed methods study","volume":"30","author":"Tolotti","year":"2019","journal-title":"Ann Oncol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00520-010-1042-3","article-title":"Perception of healthcare providers versus patient reported incidence of chemotherapy-induced nausea and vomiting after the addition of NK-1 receptor antagonists","volume":"19","author":"Majem","year":"2011","journal-title":"Support Care Cancer"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.7314\/APJCP.2014.15.8.3533","article-title":"Health-related quality of life in women with breast cancer: a literature-based review of psychometric properties of breast cancer-specific measures","volume":"15","author":"Niu","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R15-20230915","first-page":"204","article-title":"Adherence and safety study in patients on treatment with capecitabine","volume":"41","author":"Fern\u00e1ndez-Ribeiro","year":"2017","journal-title":"Farm Hosp"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7525-9-3","article-title":"Heath-related quality of life in Spanish breast cancer patients: a systematic review","volume":"9","author":"Delgado-Sanz","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11764-012-0247-5","article-title":"Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes","volume":"7","author":"Pusic","year":"2013","journal-title":"J Cancer Surviv"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1634\/theoncologist.2013-0359","article-title":"Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects","volume":"19","author":"Beusterien","year":"2014","journal-title":"Oncologist"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1200\/JCO.2005.04.1665","article-title":"Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"24","author":"Bear","year":"2006","journal-title":"J Clin Oncol"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.3816\/CBC.2002.s.015","article-title":"Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial","volume":"3","author":"Heys","year":"2002","journal-title":"Clin Breast Cancer"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2005.06.156","article-title":"Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study","volume":"23","author":"Evans","year":"2005","journal-title":"J Clin Oncol"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1470-2045(12)70525-9","article-title":"Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial","volume":"14","author":"Mackey","year":"2013","journal-title":"Lancet Oncol"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1056\/NEJMoa043681","article-title":"Adjuvant docetaxel for node-positive breast cancer","volume":"352","author":"Martin","year":"2005","journal-title":"N Engl J Med"},{"issue":"(14_suppl)","key":"R24-20230915","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1200\/jco.2004.22.90140.620","article-title":"Prophylactic growth factor (GF) support with adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-negative breast cancer (BC): an interim safety analysis of the GEICAM 9805 study","volume":"22","author":"Martin","year":"2004","journal-title":"J Clin Oncol"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1200\/JCO.2012.48.1275","article-title":"Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial","volume":"31","author":"Swain","year":"2013","journal-title":"J Clin Oncol"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa0910320","article-title":"Adjuvant docetaxel for high-risk, node-negative breast cancer","volume":"363","author":"Mart\u00edn","year":"2010","journal-title":"N Engl J Med"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(76)92112-7","article-title":"Evaluation of quality of life in patients receiving treatment for advanced breast cancer","volume":"24","author":"Priestman","year":"1976","journal-title":"Lancet"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/14737167.2016.1146594","article-title":"Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments","volume":"16","author":"Schwenkglenks","year":"2016","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00019053-200725050-00002","article-title":"Health utilities using the EQ-5D in studies of cancer","volume":"25","author":"Pickard","year":"2007","journal-title":"Pharmacoeconomics"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12955-015-0399-x","article-title":"Validity and reliability of EQ-5D-3L for breast cancer patients in Korea","volume":"13","author":"Kim","year":"2015","journal-title":"Health Qual Life Outcomes"},{"key":"R32-20230915","first-page":"54","article-title":"Cambios del modo y estilo de vida; su influencia en el proceso salud-enfermedad","volume":"41","author":"Espinosa-Gonz\u00e1lez","year":"2004","journal-title":"Rev Cubana Estomatol"},{"key":"R33-20230915","first-page":"10","article-title":"Causas e impacto cl\u00ednico de la desnutrici\u00f3n y caquexia en el paciente oncol\u00f3gico","volume":"21","author":"Garc\u00eda-Luna","year":"2006","journal-title":"Nutr Hosp"},{"key":"R34-20230915","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1200\/JCO.2011.38.7605","article-title":"Quality of breast cancer care: perception versus practice","volume":"30","author":"Bickell","year":"2012","journal-title":"J Clin Oncol"},{"key":"R35-20230915","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/cncr.21343","article-title":"Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy","volume":"104","author":"Herrstedt","year":"2005","journal-title":"Cancer"},{"key":"R36-20230915","doi-asserted-by":"crossref","first-page":"e2718","DOI":"10.1136\/bmj.e2718","article-title":"Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13722 women","volume":"344","author":"Kesson","year":"2012","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:18:01Z","timestamp":1694827081000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":34,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021695","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]}}}